Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Pellegrini V, Municinò M, Siniscalchi M, Spinetti F, Vigliotti G, Vecchione C, Carrizzo A, Accarino G, Squillante A, Spaziano G, Mirra D, Esposito R, Altieri S, Falco G, Fenti A, Galoppo S, Canzano S, Sasso FC, Matacchione G, Olivieri F, Ferraraccio F, Panarese I, Paolisso P, Barbato E, Lubritto C, Balestrieri ML, Mauro C, Caballero AE, Rajagopalan S, Ceriello A, D'Agostino B, Iovino P, Paolisso G. Marfella R, et al. Among authors: frige c. N Engl J Med. 2024 Mar 7;390(10):900-910. doi: 10.1056/NEJMoa2309822. N Engl J Med. 2024. PMID: 38446676
Weight variability and diabetes complications.
Prattichizzo F, Frigé C, La Grotta R, Ceriello A. Prattichizzo F, et al. Among authors: frige c. Diabetes Res Clin Pract. 2023 May;199:110646. doi: 10.1016/j.diabres.2023.110646. Epub 2023 Mar 29. Diabetes Res Clin Pract. 2023. PMID: 37001818 Review.
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
Marfella R, Prattichizzo F, Sardu C, Paolisso P, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Ferraraccio F, Panarese I, Fanelli M, Modugno P, Calafiore AM, Melchionna M, Sasso FC, Furbatto F, D'Andrea D, Siniscalchi M, Mauro C, Cesaro A, Calabrò P, Santulli G, Balestrieri ML, Barbato E, Ceriello A, Paolisso G. Marfella R, et al. Among authors: frige c. Atherosclerosis. 2023 Aug;378:117180. doi: 10.1016/j.atherosclerosis.2023.06.971. Epub 2023 Jun 29. Atherosclerosis. 2023. PMID: 37422356
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R, Sardu C, D'Onofrio N, Fumagalli C, Scisciola L, Sasso FC, Siniscalchi M, Marfella LV, D'Andrea D, Minicucci F, Signoriello G, Cesaro A, Trotta MC, Frigé C, Prattichizzo F, Balestrieri ML, Ceriello A, Calabrò P, Mauro C, Del Viscovo L, Paolisso G. Marfella R, et al. Among authors: frige c. BMC Med. 2023 Feb 24;21(1):71. doi: 10.1186/s12916-023-02781-2. BMC Med. 2023. PMID: 36829203 Free PMC article.
Organ-specific biological clocks: Ageotyping for personalized anti-aging medicine.
Prattichizzo F, Frigé C, Pellegrini V, Scisciola L, Santoro A, Monti D, Rippo MR, Ivanchenko M, Olivieri F, Franceschi C. Prattichizzo F, et al. Among authors: frige c. Ageing Res Rev. 2024 Apr;96:102253. doi: 10.1016/j.arr.2024.102253. Epub 2024 Mar 4. Ageing Res Rev. 2024. PMID: 38447609 Review.
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes.
Ceriello A, Lucisano G, Prattichizzo F, La Grotta R, Frigé C, De Cosmo S, Di Bartolo P, Di Cianni G, Fioretto P, Giorda CB, Pontremoli R, Russo G, Viazzi F, Nicolucci A; AMD Annals study group. Ceriello A, et al. Among authors: frige c. Lancet Reg Health Eur. 2023 Jun 12;31:100666. doi: 10.1016/j.lanepe.2023.100666. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37547276 Free PMC article.
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R, Prattichizzo F, Sardu C, Rambaldi PF, Fumagalli C, Marfella LV, La Grotta R, Frigé C, Pellegrini V, D'Andrea D, Cesaro A, Calabrò P, Pizzi C, Antonicelli R, Ceriello A, Mauro C, Paolisso G. Marfella R, et al. Among authors: frige c. Cardiovasc Diabetol. 2024 Jan 6;23(1):10. doi: 10.1186/s12933-023-02118-6. Cardiovasc Diabetol. 2024. PMID: 38184582 Free PMC article.